Punjab National Bank Fund Raise of ₹14,250 Cr

Punjab National Bank Other Announcement

Punjab National Bank revised its MCLR across tenors, effective 1 November 2026, with rises of 10 basis points. RLLR and Base Rate remain unchanged.

Punjab National Bank Legal & Regulatory

PNB disclosed an RBI monetary penalty of Rs 1.57 Crore for non-compliance with currency chest guidelines. The financial impact is limited to the penalty amount.

Value

₹1.57 Cr

Punjab National Bank Results Correction

Punjab National Bank re-submitted its unchanged September 2026 quarter and half-year results in machine-readable format. No figures, disclosures or other information were modified from the earlier filing.

Punjab National Bank Results Update

Punjab National Bank released its financial performance highlights for the quarter ended September 30, 2026. The bank reported strong growth in profitability, deposits, and total business.

Punjab National Bank Investor Presentation: Key Takeaways

PNB reported a strong Q2 FY27 with Net Profit rising 12.8% YoY to ₹5,532 Cr. Key highlights include improved asset quality (GNPA at 2.55%) and 11.9% YoY global business growth.

Punjab National Bank Q2 FY27 Results: Net Profit ₹5,561 Cr, Up 14.7% YoY

Punjab National Bank reported revenue from operations of ₹35,267 Cr (+8.5% YoY) and net profit of ₹5,561 Cr (+14.7% YoY) for Q2 FY27.

Key figure

Net profit ₹5,561 Cr · +14.7% YoY

Jindal Capital Fund Raise of ₹16.22 Cr

Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.

Value

₹16.22 Cr

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr